[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2010/132110,2010,A1Locationinpatent:Page/Pagecolumn38-39
[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2022/112951,2022,A1Locationinpatent:Paragraph0120;0121
[1]CurrentPatentAssignee:CHENGDUBRIGHBIOTECH-CN106854208,2017,A
[1]CurrentPatentAssignee:CHENGDUBRIGHBIOTECH-CN106854208,2017,A
[1]CurrentPatentAssignee:CHENGDUBRIGHBIOTECH-CN106854208,2017,A
Title: Soucy TA, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009 Apr 9;458(7239):732-6.
Title: J. Claire Godbersen, e tal. The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells.
Title: Lan H, et al. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Sci Rep. 2016 Apr 11;6:24218.